Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Choline1715 records.
Article ID | PMID | Source | Title | Publish Year | |
---|---|---|---|---|---|
A21193 | 25488932 | Drug Metab Dispos | Renal xenobiotic transporter expression is altered in multiple experimental models of nonalcoholic steatohepatitis. | 2014 | Details |
A21220 | 25470250 | PLoS One | Circulating extracellular vesicles with specific proteome and liver microRNAs are potential biomarkers for liver injury in experimental fatty liver disease. | 2014 | Details |
A21229 | 25469013 | World J Gastroenterol | Obesity, fatty liver disease and intestinal microbiota. | 2014 | Details |
A21240 | 25460293 | Horm Mol Biol Clin Investig | Nutrition: a promising route for prevention and management of obesity-related nonalcoholic fatty liver disease. | 2014 | Details |
A21257 | 25451254 | Biochem Biophys Res Commun | Apolipoprotein A-I expression suppresses COX-2 expression by reducing reactive oxygen species in hepatocytes. | 2014 | Details |
A21263 | 25450212 | J Hepatol | Circulating phospholipid profiling identifies portal contribution to NASH signature in obesity. | 2014 | Details |
A21268 | 25445436 | Life Sci | Beneficial effects of phosphatidylcholine on high-fat diet-induced obesity, hyperlipidemia and fatty liver in mice. | 2014 | Details |
A21272 | 25443620 | Liver Int | The indole derivative NecroX-7 improves nonalcoholic steatohepatitis in ob/ob mice through suppression of mitochondrial ROS/RNS and inflammation. | 2015 | Details |
A21294 | 25428903 | Am J Physiol Gastrointest Liver Physiol | Mosapride citrate improves nonalcoholic steatohepatitis with increased fecal lactic acid bacteria and plasma glucagon-like peptide-1 level in a rodent model. | 2014 | Details |
A21303 | 25421042 | Mol Med Rep | Reduction of endotoxin attenuates liver fibrosis through suppression of hepatic stellate cell activation and remission of intestinal permeability in a rat non-alcoholic steatohepatitis model. | 2014 | Details |
A21322 | 25406833 | J Transl Med | Hepatoprotective and antioxidant activities of extracts from Salvia-Nelumbinis naturalis against nonalcoholic steatohepatitis induced by methionine- and choline-deficient diet in mice. | 2014 | Details |
A21364 | 25372401 | PLoS One | Pharmacological inhibition of the chemokine CXCL16 diminishes liver macrophage infiltration and steatohepatitis in chronic hepatic injury. | 2014 | Details |
A21402 | 25347994 | J Pharmacol Exp Ther | M1 polarization bias and subsequent nonalcoholic steatohepatitis progression is attenuated by nitric oxide donor DETA NONOate via inhibition of CYP2E1-induced oxidative stress in obese mice. | 2014 | Details |
A21419 | 25333350 | Mol Med Rep | Inhibition of aldose reductase ameliorates diet-induced nonalcoholic steatohepatitis in mice via modulating the phosphorylation of hepatic peroxisome proliferator-activated receptor α. | 2014 | Details |
A21424 | 25330059 | Cell Transplant | Preoperative hepatocyte transplantation improves the survival of rats with nonalcoholic steatohepatitis-related cirrhosis after partial hepatectomy. | 2014 | Details |
A21433 | 25320186 | J Nutr | Higher dietary choline intake is associated with lower risk of nonalcoholic fatty liver in normal-weight Chinese women. | 2014 | Details |
A21441 | 25316683 | JPEN J Parenter Enteral Nutr | Branched-Chain Amino Acid-Rich Supplements Containing Microelements Have Antioxidant Effects on Nonalcoholic Steatohepatitis in Mice. | 2014 | Details |
A21477 | 25294219 | Toxicol Sci | Activation of the Nrf2-ARE pathway in hepatocytes protects against steatosis in nutritionally induced non-alcoholic steatohepatitis in mice. | 2014 | Details |
A21488 | 25281898 | Int Immunopharmacol | 3, 3'-Diindolylmethane alleviates steatosis and the progression of NASH partly through shifting the imbalance of Treg/Th17 cells to Treg dominance. | 2014 | Details |
A21489 | 25281863 | J Hepatol | Acid sphingomyelinase-ceramide system in steatohepatitis: a novel target regulating multiple pathways. | 2014 | Details |
A21497 | 25274101 | Br J Nutr | Non-alcoholic fatty liver disease: need for a balanced nutritional source. | 2014 | Details |
A21502 | 25270373 | Acta Radiol | High resolution in vivo 31P-MRS of the liver: potential advantages in the assessment of non-alcoholic fatty liver disease. | 2014 | Details |
A21503 | 25269746 | Mol Med Rep | Upregulated microRNA-199a-5p inhibits nuclear receptor corepressor 1 translation in mice with non‑alcoholic steatohepatitis. | 2014 | Details |
A21521 | 25256357 | J Nutr Biochem | Interstrain differences in the progression of nonalcoholic steatohepatitis to fibrosis in mice are associated with altered hepatic iron metabolism. | 2014 | Details |
A21522 | 25256142 | J Cell Mol Med | ASPP2 attenuates triglycerides to protect against hepatocyte injury by reducing autophagy in a cell and mouse model of non-alcoholic fatty liver disease. | 2014 | Details |
A21656 | 25145655 | Toxicol Sci | Systems level metabolic phenotype of methotrexate administration in the context of non-alcoholic steatohepatitis in the rat. | 2014 | Details |
A21683 | 25122558 | FASEB J | Protective role of macrophage migration inhibitory factor in nonalcoholic steatohepatitis. | 2014 | Details |
A21733 | 25083607 | Gastroenterology | Fibroblast growth factor 21 limits lipotoxicity by promoting hepatic fatty acid activation in mice on methionine and choline-deficient diets. | 2014 | Details |
A21741 | 25080921 | Toxicol Sci | Increased susceptibility to methotrexate-induced toxicity in nonalcoholic steatohepatitis. | 2014 | Details |
A21763 | 25063232 | Int J Biochem Cell Biol | Exercise alters liver mitochondria phospholipidomic profile and mitochondrial activity in non-alcoholic steatohepatitis. | 2014 | Details |
A21765 | 25061561 | Mol Metab | Methyl-donor supplementation in obese mice prevents the progression of NAFLD, activates AMPK and decreases acyl-carnitine levels. | 2014 | Details |
A21776 | 25051256 | Mol Med Rep | Protective effects and mechanisms of total alkaloids of Rubus alceaefolius Poir on non‑alcoholic fatty liver disease in rats. | 2014 | Details |
A21781 | 25048951 | J Hepatol | CXCL10 plays a key role as an inflammatory mediator and a non-invasive biomarker of non-alcoholic steatohepatitis. | 2014 | Details |
A21796 | 25040043 | Liver Int | microRNA-122 regulates hypoxia-inducible factor-1 and vimentin in hepatocytes and correlates with fibrosis in diet-induced steatohepatitis. | 2014 | Details |
A21821 | 25024595 | World J Gastroenterol | Experimental models of non-alcoholic fatty liver disease in rats. | 2014 | Details |
A21838 | 25011936 | Gut | Enhanced expression of BMP6 inhibits hepatic fibrosis in non-alcoholic fatty liver disease. | 2014 | Details |
A21861 | 24993337 | Int J Mol Med | Exendin‑4, a glucagon‑like peptide‑1 receptor agonist, modulates hepatic fatty acid composition and Δ‑5‑desaturase index in a murine model of non‑alcoholic steatohepatitis. | 2014 | Details |
A21875 | 24987492 | Oxid Med Cell Longev | Serum oxidative stress markers and lipidomic profile to detect NASH patients responsive to an antioxidant treatment: a pilot study. | 2014 | Details |
A21896 | 24975216 | J Nutr Sci Vitaminol (Tokyo) | Retinol status and expression of retinol-related proteins in methionine-choline deficient rats. | 2014 | Details |
A21947 | 24946279 | J Hepatol | ASMase regulates autophagy and lysosomal membrane permeabilization and its inhibition prevents early stage non-alcoholic steatohepatitis. | 2014 | Details |
A21952 | 24941342 | Molecules | Standardized Salvia miltiorrhiza extract suppresses hepatic stellate cell activation and attenuates steatohepatitis induced by a methionine-choline deficient diet in mice. | 2014 | Details |
A21956 | 24937020 | Eur J Pharmacol | Treatment with baicalein attenuates methionine-choline deficient diet-induced non-alcoholic steatohepatitis in rats. | 2014 | Details |
A21979 | 24918580 | PLoS One | Gallic acid ameliorated impaired glucose and lipid homeostasis in high fat diet-induced NAFLD mice. | 2014 | Details |
A22008 | 24895482 | J Clin Biochem Nutr | The α-tocopherol status and expression of α-tocopherol-related proteins in methionine-choline deficient rats treated with vitamin E. | 2014 | Details |
A22031 | 24865256 | Dig Dis Sci | Tauroursodeoxycholic acid attenuates progression of steatohepatitis in mice fed a methionine-choline-deficient diet. | 2014 | Details |
A22036 | 24861026 | J Mol Med (Berl) | NLRP3 inflammasome activation is required for fibrosis development in NAFLD. | 2014 | Details |
A22039 | 24857839 | Arch Biochem Biophys | Metabolomics-based search for therapeutic agents for non-alcoholic steatohepatitis. | 2014 | Details |
A22045 | 24853141 | PLoS One | HCC development is associated to peripheral insulin resistance in a mouse model of NASH. | 2014 | Details |
A22054 | 24849253 | PLoS One | Deletion of nardilysin prevents the development of steatohepatitis and liver fibrotic changes. | 2014 | Details |
A22061 | 24845607 | J Hepatol | Hepatocyte specific deletion of c-Met leads to the development of severe non-alcoholic steatohepatitis in mice. | 2014 | Details |
A22082 | 24830603 | Exp Mol Pathol | Lipidomic analysis of the liver from high-fat diet induced obese mice identifies changes in multiple lipid classes. | 2014 | Details |
A22138 | 24795036 | Dig Dis Sci | Caspase 3 inactivation protects against hepatic cell death and ameliorates fibrogenesis in a diet-induced NASH model. | 2014 | Details |
A22210 | 24747563 | Biochem Biophys Res Commun | Bile acids override steatosis in farnesoid X receptor deficient mice in a model of non-alcoholic steatohepatitis. | 2014 | Details |
A22216 | 24743734 | Cell Death Dis | Impaired autophagic flux is associated with increased endoplasmic reticulum stress during the development of NAFLD. | 2014 | Details |
A22250 | 24719358 | FASEB J | Plasma membrane phospholipase A2 controls hepatocellular fatty acid uptake and is responsive to pharmacological modulation: implications for nonalcoholic steatohepatitis. | 2014 | Details |
A22258 | 24714086 | Int J Mol Sci | Fatty acid elongation in non-alcoholic steatohepatitis and hepatocellular carcinoma. | 2014 | Details |
A22263 | 24708244 | Endocrinology | GH administration rescues fatty liver regeneration impairment by restoring GH/EGFR pathway deficiency. | 2014 | Details |
A22270 | 24702805 | Chin J Nat Med | Effect of Trifolium pratense extract on methionine-choline-deficient diet-induced steatohepatitis in C57BL/6 mice. | 2014 | Details |
A22317 | 24668763 | Hepatology | Endogenous annexin A1 is a novel protective determinant in nonalcoholic steatohepatitis in mice. | 2014 | Details |
A22335 | 24652102 | J Gastroenterol | The role of diet on intestinal microbiota metabolism: downstream impacts on host immune function and health, and therapeutic implications. | 2014 | Details |
A22343 | 24650018 | Liver Int | Both bone marrow-derived and non-bone marrow-derived cells contribute to AIM2 and NLRP3 inflammasome activation in a MyD88-dependent manner in dietary steatohepatitis. | 2014 | Details |
A22382 | 24628836 | Liver Int | n-3 polyunsaturated fatty acids worsen inflammation and fibrosis in experimental nonalcoholic steatohepatitis. | 2014 | Details |
A22392 | 24622832 | J Physiol Pharmacol | Effects of treatment with melatonin and tryptophan on liver enzymes, parameters of fat metabolism and plasma levels of cytokines in patients with non-alcoholic fatty liver disease--14 months follow up. | 2014 | Details |
A22401 | 24613363 | J Hepatol | Synergistic interaction between genetics and disease on pravastatin disposition. | 2014 | Details |
A22417 | 24595150 | J Int Med Res | Fatty liver and serum cholinesterase are independently correlated with HbA1c levels: cross-sectional analysis of 5384 people. | 2014 | Details |
A22418 | 24594481 | Biochim Biophys Acta | Role of adipose tissue in methionine-choline-deficient model of non-alcoholic steatohepatitis (NASH). | 2014 | Details |
A22487 | 24520780 | Zhongguo Zhong Xi Yi Jie He Za Zhi | [Treatment of nonalcoholic steatohepatitis by Jianpi Shugan Recipe: a multi-center, randomized, controlled clinical trial]. | 2014 | Details |
A22489 | 24520264 | Exp Ther Med | Comparison between the efficacies of curcumin and puerarin in C57BL/6 mice with steatohepatitis induced by a methionine- and choline-deficient diet. | 2013 | Details |
A22519 | 24495527 | Proc Nutr Soc | 'The way to a man's heart is through his gut microbiota'--dietary pro- and prebiotics for the management of cardiovascular risk. | 2014 | Details |
A22521 | 24492979 | Surg Today | Hydrolyzed whey peptide-based diet ameliorates hepatic ischemia-reperfusion injury in the rat nonalcoholic fatty liver. | 2014 | Details |
A22533 | 24486698 | Mol Cell Endocrinol | Nonalcoholic steatohepatitis as a novel player in metabolic syndrome-induced erectile dysfunction: an experimental study in the rabbit. | 2014 | Details |
A22539 | 24480733 | Arch Med Res | Time-dependent changes and association between liver free fatty acids, serum lipid profile and histological features in mice model of nonalcoholic fatty liver disease. | 2014 | Details |
A22553 | 24466347 | PLoS One | Inhibitory effects of Japanese herbal medicines sho-saiko-to and juzen-taiho-to on nonalcoholic steatohepatitis in mice. | 2014 | Details |
A22573 | 24454937 | PLoS One | Lipid metabolism, oxidative stress and cell death are regulated by PKC delta in a dietary model of nonalcoholic steatohepatitis. | 2014 | Details |
A22583 | 24445049 | J Nutr Biochem | Sesame oil mitigates nutritional steatohepatitis via attenuation of oxidative stress and inflammation: a tale of two-hit hypothesis. | 2013 | Details |
A22619 | 24403518 | J Pharmacol Exp Ther | Experimental nonalcoholic steatohepatitis increases exposure to simvastatin hydroxy acid by decreasing hepatic organic anion transporting polypeptide expression. | 2014 | Details |
A22620 | 24402912 | J Cell Biochem | HIF-1α expression as a protective strategy of HepG2 cells against fatty acid-induced toxicity. | 2014 | Details |
A22667 | 24375162 | Iran Biomed J | Prevention of nonalcoholic steatohepatitis in rats by two manganese-salen complexes. | 2014 | Details |
A22679 | 26417275 | EXCLI J | Non-alcoholic fatty liver disease, diet and gut microbiota. | 2014 | Details |
A22705 | 24368431 | J Nutr | Choline supplementation protects against liver damage by normalizing cholesterol metabolism in Pemt/Ldlr knockout mice fed a high-fat diet. | 2013 | Details |
A22728 | 24353111 | Biofactors | Novel insights on interactions between folate and lipid metabolism. | 2013 | Details |
A22753 | 24329600 | J Gastroenterol Hepatol | Attenuation of steatohepatitis, fibrosis, and carcinogenesis in mice fed a methionine-choline deficient diet by CCAAT/enhancer-binding protein homologous protein deficiency. | 2014 | Details |
A22760 | 24325816 | BMB Rep | The expression and secretion of vimentin in the progression of non-alcoholic steatohepatitis. | 2014 | Details |
A22761 | 24325457 | J Med Food | The effects of α-lipoic acid on liver oxidative stress and free fatty acid composition in methionine-choline deficient diet-induced NAFLD. | 2013 | Details |
A22775 | 24316518 | J Hepatol | Dietary glycotoxins exacerbate progression of experimental fatty liver disease. | 2013 | Details |
A22799 | 24295779 | Biochim Biophys Acta | Omega-3 phospholipids from fish suppress hepatic steatosis by integrated inhibition of biosynthetic pathways in dietary obese mice. | 2014 | Details |
A22801 | 24294355 | Int J Clin Exp Pathol | Morphological and functional characterization of non-alcoholic fatty liver disease induced by a methionine-choline-deficient diet in C57BL/6 mice. | 2013 | Details |
A22805 | 24291241 | J Hepatol | Non-alcoholic fatty liver disease: spectral patterns observed from an in vivo phosphorus magnetic resonance spectroscopy study. | 2013 | Details |
A22847 | 24274865 | Clin Liver Dis | Obesity and NAFLD: the role of bacteria and microbiota. | 2013 | Details |
A22853 | 24251710 | J Gastroenterol Hepatol | Role of diet and nutritional management in non-alcoholic fatty liver disease. | 2013 | Details |
A22914 | 24217942 | J Appl Toxicol | Circulating microRNA 122 in the methionine and choline-deficient mouse model of non-alcoholic steatohepatitis. | 2013 | Details |
A22931 | 24197250 | J Gastroenterol | Combination of sorafenib and angiotensin-II receptor blocker attenuates preneoplastic lesion development in a non-diabetic rat model of steatohepatitis. | 2013 | Details |
A22939 | 24190226 | Int J Mol Med | Hypertension exacerbates liver injury and hepatic fibrosis induced by a choline-deficient L-amino acid-defined diet in rats. | 2013 | Details |
A22953 | 24179615 | World J Hepatol | Rapid chromatographic method to decipher distinct alterations in lipid classes in NAFLD/NASH. | 2013 | Details |
A22971 | 24157968 | Am J Physiol Gastrointest Liver Physiol | Purinergic receptor X7 is a key modulator of metabolic oxidative stress-mediated autophagy and inflammation in experimental nonalcoholic steatohepatitis. | 2013 | Details |
A22995 | 24130212 | Hum Exp Toxicol | Dynamics of oxidative/nitrosative stress in mice with methionine-choline-deficient diet-induced nonalcoholic fatty liver disease. | 2013 | Details |
A23012 | 24117897 | J Gastroenterol Hepatol | Effects of treatment with hydrogen sulfide on methionine-choline deficient diet-induced non-alcoholic steatohepatitis in rats. | 2014 | Details |
A23016 | 24115128 | Hepatology | Adaptive immune responses triggered by oxidative stress contribute to hepatic inflammation in NASH. | 2014 | Details |
A23020 | 24113768 | Am J Physiol Gastrointest Liver Physiol | Lactobacillus casei strain Shirota protects against nonalcoholic steatohepatitis development in a rodent model. | 2013 | Details |
A23041 | 24084163 | Mol Genet Metab | Transcriptomic and epigenetic changes in early liver steatosis associated to obesity: effect of dietary methyl donor supplementation. | 2013 | Details |